Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-02-14 15:10 Tx date 2024-02-14 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
$2,271
+8,572 vol $0.265 each |
21,965 | |
Filed 2024-02-14 15:08 Tx date 2024-02-14 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-3,549.145
-13,393 vol $0.265 each |
0 | |
Filed 2023-11-29 13:01 Tx date 2023-11-29 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
+13,393 vol |
13,393 | |
Filed 2023-11-29 13:00 Tx date 2023-11-29 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
57 - Exercise of rights
|
-13,393 vol |
13,393 | |
Filed 2023-03-17 10:16 Tx date 2023-03-15 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$66,000
+100,000 vol $0.66 each |
275,000 | |
Filed 2023-01-29 10:51 Tx date 2023-01-27 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$15,000
+26,786 vol $0.56 each |
26,786 | |
Filed 2023-01-29 10:49 Tx date 2021-06-15 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-05-02 12:12 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
175,000 | |
Filed 2021-12-10 12:54 Tx date 2021-12-09 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024
16 - Acquisition or disposition under a prospectus exemption
|
+$20,000 vol |
$20,000 | |
Filed 2021-12-10 12:53 Tx date 2021-06-15 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-17 09:59 Tx date 2021-06-15 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
150,000 | |
Filed 2021-06-17 09:58 Tx date 2021-06-15 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-17 09:57 Tx date 2021-06-15 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|